Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by the ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $247.61 which represents a slight increase of $0.01 or 0.00% from the prior close of $247.6. The stock opened at $248.13 and ...

Shares of Becton Dickinson and Co (NYSE:BDX) climbed 3.3% following news that activist investor Starboard Value has acquired ...

Investing.com -- Becton Dickinson and Co (NYSE:BDX)的股价上涨3.3%，此前有消息称激进投资者Starboard Value已收购了该医疗技术公司的股份。

Becton Dickinson & Co. closed 3.80% short of its 52-week high of $251.99, which the company reached on February 3rd.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Becton Dickinson (BDX – Research Report), Idexx Laboratories ...

Starboard Value has taken a stake in Becton Dickinson (BDX) and is pushing the medical technology company to sell its life sciences division, ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

Besides Wall Street's top -and-bottom-line estimates for Becton Dickinson (BDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared ...

U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of ...

根据最近的SEC文件显示，领先的医疗技术公司Becton Dickinson & Co (NYSE: BDX )宣布了周一举行的2025年度股东大会的结果。股东就几项关键提案进行了投票，包括董事选举和公司独立审计师的批准。